[go: up one dir, main page]

CL2019002220A1 - Gasotransmisor electroquímico que genera composiciones y métodos de uso de los mismos y apósitos y sistemas de tratamiento que incorpora los mismos. - Google Patents

Gasotransmisor electroquímico que genera composiciones y métodos de uso de los mismos y apósitos y sistemas de tratamiento que incorpora los mismos.

Info

Publication number
CL2019002220A1
CL2019002220A1 CL2019002220A CL2019002220A CL2019002220A1 CL 2019002220 A1 CL2019002220 A1 CL 2019002220A1 CL 2019002220 A CL2019002220 A CL 2019002220A CL 2019002220 A CL2019002220 A CL 2019002220A CL 2019002220 A1 CL2019002220 A1 CL 2019002220A1
Authority
CL
Chile
Prior art keywords
gasotransmitter
methods
compositions
electrochemical
dressings
Prior art date
Application number
CL2019002220A
Other languages
English (en)
Inventor
Alan Willey
Steven Samuel
Original Assignee
Noxsano Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noxsano Inc filed Critical Noxsano Inc
Publication of CL2019002220A1 publication Critical patent/CL2019002220A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01008—Non-adhesive bandages or dressings characterised by the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/48—Sulfur dioxide; Sulfurous acid
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B21/00—Nitrogen; Compounds thereof
    • C01B21/20—Nitrogen oxides; Oxyacids of nitrogen; Salts thereof
    • C01B21/50—Nitrous acid; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a composiciones que comprenden un mediador orgánico electroquímico y una sal gasotransmisora que se convierte en un gasotransmisor por transferencia de electrones. También se divulgan vendas y vendajes que comprenden el gasotransmisor y métodos de elaboración de gasotransmisores, que comprende exponer las composiciones a un voltaje suficiente para reducir el mediador orgánico soluble en agua. Ader'nás se divulgan métodos de tratamiento para una variedad de estados de trauma y enfermedades mediante la aplicación de una cantidad terapéuticamente efectiva de al menos un gasotransmisor a los mismos, y métodos de generar una dosis efectiva de la gasotransmisor generados de reacción electrolítica que afecta (as composiciones de la generación del gasotransmisor.
CL2019002220A 2017-02-09 2019-08-07 Gasotransmisor electroquímico que genera composiciones y métodos de uso de los mismos y apósitos y sistemas de tratamiento que incorpora los mismos. CL2019002220A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762457039P 2017-02-09 2017-02-09

Publications (1)

Publication Number Publication Date
CL2019002220A1 true CL2019002220A1 (es) 2020-01-03

Family

ID=63038868

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019002220A CL2019002220A1 (es) 2017-02-09 2019-08-07 Gasotransmisor electroquímico que genera composiciones y métodos de uso de los mismos y apósitos y sistemas de tratamiento que incorpora los mismos.

Country Status (14)

Country Link
US (1) US10342706B2 (es)
EP (1) EP3579888B1 (es)
JP (1) JP6989157B2 (es)
KR (1) KR102189597B1 (es)
CN (1) CN110461374B (es)
AU (1) AU2018218200B2 (es)
CA (1) CA3053141A1 (es)
CL (1) CL2019002220A1 (es)
ES (1) ES2965705T3 (es)
IL (1) IL268577B (es)
MX (1) MX389787B (es)
PL (1) PL3579888T3 (es)
WO (1) WO2018147986A1 (es)
ZA (1) ZA201905431B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190328774A1 (en) * 2017-02-09 2019-10-31 Noxsano Inc. Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same
JP2021522221A (ja) * 2018-04-25 2021-08-30 ノクサノ インコーポレイテッド 光活性化ガス伝達物質生成組成物
JP7396598B2 (ja) * 2018-06-08 2023-12-12 住友精化株式会社 皮膚創傷用組成物
KR20210019434A (ko) 2018-06-08 2021-02-22 스미토모 세이카 가부시키가이샤 염증성 소화 기관 질환용 조성물
CN113597293A (zh) * 2019-01-11 2021-11-02 诺克斯萨诺股份有限公司 电化学气体递质生成组合物和用于生成气体递质的双金属电池
TWI694844B (zh) 2019-01-29 2020-06-01 明基材料股份有限公司 硫化氫緩釋敷料及其製造方法
CN109793919B (zh) * 2019-02-01 2022-01-14 明基材料（芜湖）有限公司 硫化氢缓释敷料及其制造方法
US20220257642A1 (en) * 2019-06-04 2022-08-18 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
EP3980373A1 (en) * 2019-06-04 2022-04-13 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
US20230087246A1 (en) * 2020-01-30 2023-03-23 3M Innovative Properties Company Delivery system for aqueous zinc oral care compositions with fluoride
CN115382095B (zh) * 2022-08-21 2025-08-08 兰州理工大学 超级电容器、应用超级电容器的伤口敷料，以及制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US20090036516A1 (en) * 2003-01-13 2009-02-05 Ctg Pharma S.R.L. Compounds for treating metabolic syndrome
KR101538727B1 (ko) * 2006-10-05 2015-07-22 이카리아 인코포레이티드 액체 칼코게나이드 조성물 및 이의 제조방법과 사용방법
WO2009155689A1 (en) * 2008-06-24 2009-12-30 Micropharma Limited Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections
WO2011082375A2 (en) * 2009-12-31 2011-07-07 Ohio University Systems and methods for promoting wound healing
JP6258853B2 (ja) * 2011-09-14 2018-01-10 スリーエム イノベイティブ プロパティズ カンパニー 弁付きの陽圧医療用ドレッシング材及びそれを含むキット
MX2014003288A (es) * 2011-09-14 2017-03-09 Nuevas Alternativas Naturales S A P I De C V Preparacion y composiciones de azufre con valencia cero, altamente bio-disponibles, y sus usos.
US9480785B2 (en) * 2012-03-30 2016-11-01 The Regents Of The University Of Michigan Nitric oxide delivery devices
EP2830698B1 (en) * 2012-03-30 2019-03-13 The Regents Of The University Of Michigan Nitric oxide delivery devices
BR102013022095A2 (pt) * 2013-08-29 2016-08-02 Mineração Tabiporã Ltda processo para a obtenção de sulfeto de hidrogênio a partir da redução de sulfato de cálcio e da decomposição do sulfeto de cálcio com cloreto de magnésio
JP6568519B2 (ja) * 2013-11-07 2019-08-28 ビーエスエヌ メディカル ゲーエムベーハー 医療用被覆器具

Also Published As

Publication number Publication date
ES2965705T3 (es) 2024-04-16
BR112019016486A2 (pt) 2020-04-07
IL268577A (en) 2019-09-26
EP3579888C0 (en) 2023-09-27
JP2020511526A (ja) 2020-04-16
CA3053141A1 (en) 2018-08-16
ZA201905431B (en) 2020-05-27
MX2019009384A (es) 2019-12-11
IL268577B (en) 2020-03-31
KR20190108169A (ko) 2019-09-23
AU2018218200B2 (en) 2023-11-23
MX389787B (es) 2025-03-19
US10342706B2 (en) 2019-07-09
CN110461374A (zh) 2019-11-15
PL3579888T3 (pl) 2024-05-27
KR102189597B1 (ko) 2020-12-14
AU2018218200A1 (en) 2019-08-29
EP3579888A4 (en) 2021-04-07
EP3579888A1 (en) 2019-12-18
US20180221210A1 (en) 2018-08-09
EP3579888B1 (en) 2023-09-27
JP6989157B2 (ja) 2022-01-05
CN110461374B (zh) 2022-05-31
WO2018147986A1 (en) 2018-08-16

Similar Documents

Publication Publication Date Title
CL2019002220A1 (es) Gasotransmisor electroquímico que genera composiciones y métodos de uso de los mismos y apósitos y sistemas de tratamiento que incorpora los mismos.
CO2020006523A2 (es) Compuestos moduladores de sting y métodos de elaboración y uso
CL2021001292A1 (es) Terapia de combinación que incluye un inhibidor de krasg12c y uno o más agentes farmacéuticamente activos adicionales para el tratamiento de cánceres
CO2020009225A2 (es) Análogos de dihidrobenzofurano e indeno como inhibidores del sarcómero cardíaco
CL2020002695A1 (es) Péptidos macrocíclicos contra actinetobacter baumannii
UY38160A (es) Partículas implantables y métodos relacionados
CL2019002204A1 (es) Compuestos inhibidores del vih.
PH12020552148A1 (en) Purinone compounds and their use in treating cancer
UY37461A (es) 1,2,4 – triazolonas 2,4,5 trisustituida
EA201791094A1 (ru) Аналоги простых эфиров фосфолипидов в качестве носителей лекарственных средств, нацеленных на раковые клетки
CL2024000560A1 (es) Inhibidores de indolina de kif18a
PH12021500034A1 (en) Compounds useful in hiv therapy
CL2021001388A1 (es) Compuestos útiles en la terapia para el vih
CO2022000481A2 (es) Inhibidores de enzimas
CL2023002549A1 (es) Ciertos compuestos de pladienolida y métodos de uso (divisional).
PE20211113A1 (es) Agentes de liberacion de gas antimicrobianos y sistemas y metodos para utilizarlos
DOP2019000100A (es) Derivados de naftiridinona y su uso en el tratamiento de la arritmia
MX2021015543A (es) Derivado de pirimidina que inhibe el crecimiento de celulas cancerosas y uso medicinal del mismo.
DOP2018000174A (es) Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
CL2020003367A1 (es) Composición que comprende el oligonucleótido antisentido y su uso para el tratamiento de la distrofia muscular de duchenne
MX2024015493A (es) Un derivado de tetrahidroisoquinolina sustituido como modulador alosterico positivo de d1
PE20181450A1 (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer
CL2021001830A1 (es) Inhibidores de lta4h para el tratamiento de la hidradenitis supurativa
MX2022015074A (es) Tratamiento antiviral.
MX2021011007A (es) Farmaco y método para tratar o prevenir las complicaciones de la diabetes mediante el uso del mismo farmaco.